{"id":799214,"date":"2025-01-09T07:33:25","date_gmt":"2025-01-09T12:33:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/"},"modified":"2025-01-09T07:33:25","modified_gmt":"2025-01-09T12:33:25","slug":"tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/","title":{"rendered":"TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference"},"content":{"rendered":"<h2>\nPresentation scheduled for Monday, January 13, 2025, at 4:30 PM PT<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>NEW YORK, Jan.  09, 2025  (GLOBE NEWSWIRE) &#8212; TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company\u2019s Chairman and Chief Executive Officer, will present at the 43<sup>rd<\/sup> Annual J.P. Morgan Healthcare Conference. The presentation is scheduled to take place on Monday, January 13, 2025, at 4:30 PM PT.<\/p>\n<p>A live webcast of this presentation will be available on the Events page, located within the Investors &amp; Media section, of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_aw0Ugg48kEioCSEltj62Bb9dLbx6FVmjjf8e_iyIGOJ4KN7xjPQWCAy3YPPBiQ2bqdg6NxL-urQg-OGOODngp9Lwybn80OK7wL2jl4Uh_g574-QZ8vUe-HbWvysBil_\" rel=\"nofollow\" target=\"_blank\">http:\/\/ir.tgtherapeutics.com\/events<\/a>. A replay of the webcast will be available on TG\u2019s website following the event.<\/p>\n<p>\n        <strong>ABOUT TG THERAPEUTICS<\/strong><br \/>\n        <br \/>TG Therapeutics\u00a0is a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has received U.S. Food and Drug Administration (FDA) approval for BRIUMVI<sup>\u00ae<\/sup> (ublituximab-xiiy), for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval by the European Commission (EC) and the Medicines and Healthcare Products Regulatory Agency (MHRA) for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features, in Europe and the United Kingdom, respectively. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2JAh85zKfTU3mYJUZU1Q0KdVTnNNQu-nmk627p9rxMEAf06kzhjUQlo2qdYO-PYCnbL7_Uw4QjUDBNTSFjhMQY37tbk0Tb2qlR3NdY_dAQQ=\" rel=\"nofollow\" target=\"_blank\">www.tgtherapeutics.com<\/a>, and follow us on Twitter\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DgGbyqGaeHpNGs-lbhag8GpWjnPyTfmSy9SykkXffqf6Ht4YW7dT_Smg77HS3uoyoWnBxr8NIPRX43McKYtZhkP2bgkeLkwqZSGA_iu8NEYY1QLcYnBhvLVKZdbKjV3OoTD73HBH9Zy1haeP4bMrw0LMRrYmwnkMnQ9Ucvc1ZJ7vfYrc4FKYjpu9xfyYDwREfrYfUaOddsnRNYrtlmIt1tGrRaWrdXVmAxlvacpwsqfTMrwV6J2RAIayrP5vBF8e\" rel=\"nofollow\" target=\"_blank\">@TGTherapeutics<\/a>\u00a0and\u00a0on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Tl1GkHyqn8UVI1jK2P456XkJTib9OEi2M55cdkjYe7-2-CFtaDFz2VKLlfcLqglIBT60TxIyz_HnQZeeGGxbqlMbWECzWKStz5ckYTSO7pK4xGnXMHyXSwPsZbzhOh91Tsl4B2NF-SGOkVI2m-7UqoxiitEYczrTp0HVvWuZAgCrh46eDQR3PTpJGDIfzkRjkUoe3Y0hmoLKn6jnxLT0Mqr_cDtDMDXs3tMHQjITpU9kpRIfyQ9Y9NxgqbRa9Q1n\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>BRIUMVI<sup>\u00ae<\/sup> is a registered trademark of TG Therapeutics, Inc.<\/p>\n<p>\n        <br \/>CONTACT:<\/p>\n<p>\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KXjH4x9S_ZmC9fvNZTItKuM_7QmI_U1jAp3Ny-_4jimhli8FNkoKEw3RS8hLHHc90A62OlPxFMaUtYPr6yg1LA==\" rel=\"nofollow\" target=\"_blank\"><u>ir@tgtxinc.com<\/u><\/a><br \/>Telephone: 1.877.575.TGTX (8489), Option 4<\/p>\n<p>\n        <strong>Media Relations<\/strong><br \/>\n        <br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JNjbh0a0MTmbdNkRaMxqmm7HmjOU7gM1NvoPBEm4q7bn989CoMQRQ6VHjc1-aWZbES_g2NzG7118HQ6X1Qu0B718RyJV_SvB51Myp2j8tzQ=\" rel=\"nofollow\" target=\"_blank\"><u>media@tgtxinc.com<\/u><\/a><br \/>Telephone: 1.877.575.TGTX (8489), Option 6<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTExNiM2Njg1ODkxIzIwMjA3OTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTBiNDcwMTgtY2ExZC00ZGU1LTlkNzMtOThlMDVkMGE0OWM4LTEwMzIxMzA=\/tiny\/TG-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Presentation scheduled for Monday, January 13, 2025, at 4:30 PM PT NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) &#8212; TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company\u2019s Chairman and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled to take place on Monday, January 13, 2025, at 4:30 PM PT. A live webcast of this presentation will be available on the Events page, located within the Investors &amp; Media section, of the Company\u2019s website at http:\/\/ir.tgtherapeutics.com\/events. A replay of the webcast will be available on TG\u2019s website following the event. ABOUT TG THERAPEUTICS TG Therapeutics\u00a0is a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition, development, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-799214","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Presentation scheduled for Monday, January 13, 2025, at 4:30 PM PT NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) &#8212; TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company\u2019s Chairman and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled to take place on Monday, January 13, 2025, at 4:30 PM PT. A live webcast of this presentation will be available on the Events page, located within the Investors &amp; Media section, of the Company\u2019s website at http:\/\/ir.tgtherapeutics.com\/events. A replay of the webcast will be available on TG\u2019s website following the event. ABOUT TG THERAPEUTICS TG Therapeutics\u00a0is a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition, development, &hellip; Continue reading &quot;TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-09T12:33:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTExNiM2Njg1ODkxIzIwMjA3OTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference\",\"datePublished\":\"2025-01-09T12:33:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\"},\"wordCount\":278,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyOTExNiM2Njg1ODkxIzIwMjA3OTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\",\"name\":\"TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyOTExNiM2Njg1ODkxIzIwMjA3OTY=\",\"datePublished\":\"2025-01-09T12:33:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyOTExNiM2Njg1ODkxIzIwMjA3OTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyOTExNiM2Njg1ODkxIzIwMjA3OTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk","og_description":"Presentation scheduled for Monday, January 13, 2025, at 4:30 PM PT NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) &#8212; TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company\u2019s Chairman and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled to take place on Monday, January 13, 2025, at 4:30 PM PT. A live webcast of this presentation will be available on the Events page, located within the Investors &amp; Media section, of the Company\u2019s website at http:\/\/ir.tgtherapeutics.com\/events. A replay of the webcast will be available on TG\u2019s website following the event. ABOUT TG THERAPEUTICS TG Therapeutics\u00a0is a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition, development, &hellip; Continue reading \"TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-09T12:33:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTExNiM2Njg1ODkxIzIwMjA3OTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference","datePublished":"2025-01-09T12:33:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/"},"wordCount":278,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTExNiM2Njg1ODkxIzIwMjA3OTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/","name":"TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTExNiM2Njg1ODkxIzIwMjA3OTY=","datePublished":"2025-01-09T12:33:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTExNiM2Njg1ODkxIzIwMjA3OTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTExNiM2Njg1ODkxIzIwMjA3OTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/799214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=799214"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/799214\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=799214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=799214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=799214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}